Edwin Tucker
Chief Tech/Sci/R&D Officer bei JASPER THERAPEUTICS, INC.
Vermögen: - $ am 31.03.2024
Profil
Edwin J.
Tucker currently works at The Royal College of Physicians, as Member and Jasper Therapeutics, Inc., as Chief Medical Officer from 2023.
Dr. Tucker also formerly worked at Genentech, Inc., as Vice President-Global Safety from 2013 to 2015, Johnson & Johnson, as Vice President-Global Safety from 2010 to 2013, Goldfinch Bio, Inc., as Chief Medical Officer, Mirum Pharmaceuticals, Inc., as Chief Medical Officer from 2019 to 2021, and Acerta Pharma LLC, as Chief Operating Officer from 2018 to 2019.
Dr. Tucker received his doctorate degree from the University of Leeds and Masters Business Admin degree from the University of Connecticut.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 15.02.2024 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Edwin Tucker
| Unternehmen | Position | Beginn |
|---|---|---|
| JASPER THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 12.06.2023 |
| The Royal College of Physicians | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Edwin Tucker
| Unternehmen | Position | Ende |
|---|---|---|
| MIRUM PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01.11.2021 |
| Acerta Pharma LLC | Compliance Officer | 01.01.2018 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01.01.2015 |
| JOHNSON & JOHNSON | Corporate Officer/Principal | 01.01.2013 |
Goldfinch Bio, Inc.
 Goldfinch Bio, Inc. Pharmaceuticals: MajorHealth Technology Goldfinch Bio, Inc. operates as a biotechnology company. It focuses on discovering and developing precision therapies for patients with kidney disease. The firm develops and manufactures medicines. The company was founded by Joseph Vincent Bonventre, Anna Greka, Fridhelm Hildebrandt, Daniel MacArthur, Stefan Somlo and Peter Mundel in December 2016 and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | - |
Ausbildung von Edwin Tucker
| University of Leeds | Doctorate Degree |
| University of Connecticut | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| JOHNSON & JOHNSON | Health Technology |
| MIRUM PHARMACEUTICALS, INC. | Health Technology |
| JASPER THERAPEUTICS, INC. | Finance |
| Private Unternehmen | 3 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Goldfinch Bio, Inc.
Goldfinch Bio, Inc. Pharmaceuticals: MajorHealth Technology Goldfinch Bio, Inc. operates as a biotechnology company. It focuses on discovering and developing precision therapies for patients with kidney disease. The firm develops and manufactures medicines. The company was founded by Joseph Vincent Bonventre, Anna Greka, Fridhelm Hildebrandt, Daniel MacArthur, Stefan Somlo and Peter Mundel in December 2016 and is headquartered in Cambridge, MA. | Health Technology |
| Acerta Pharma LLC |
